Senior Director Global Alliance Management

Other Waltham, Massachusetts


Description

Apellis is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

We believe that our lead product candidate, APL-2, has the potential to be a first-in-class treatment targeting C3 that may address the limitations of existing treatment options or provide a treatment option where there currently is none. APL-2 has already shown activity that we believe is clinically meaningful in clinical trials for two distinct medical conditions—geographic atrophy in age-related macular degeneration (GA) and paroxysmal nocturnal hemoglobinuria (PNH). We plan to conduct additional clinical trials in GA, PNH, autoimmune hemolytic anemia (AIHA) and complement-dependent nephropathies.

Senior Director Global Alliance Management:

We are searching for an experienced, hands-on professional in alliance management who will oversee the successful execution of Apellis’ partnership agreements. The Senior Director, Global Alliance Management is responsible for the activities related to alliance processes, governance procedures, alliance analysis frameworks, metrics, reporting, organizational training and external promotion of alliances. S/he is accountable for proactively and strategically managing established and new alliance relationships. The role works closely with internal stakeholders to ensure alliance strategy and operations are aligned with Apellis’ overall corporate strategy as partnered assets and partnerships evolve over time/development. The Senior Director, Global Alliance Management will be directly involved in establishing a robust reputation for Apellis as partner-of-choice through a solution-based and relationship-focused alliance management aimed at achieving mutually beneficial outcomes.

Responsibilities:

  • Lead strategic alliance budget, performance monitoring and planning, including monitoring partners’ performance and operations in coordination with business lead as well as planning and monitoring Apellis’ contractual obligations (milestones, royalties, option trigger/exercise etc.)
  • Collaborate with the Business Development team and participate in late-stage evaluation of BD opportunities with an alliance component, including assessing management risk posed by potential partner and alliance, to prepare for alliance implementation by providing contractual input and preparing for alliance start-up
  • Support new alliances and ensure a smooth transition and implementation post contract signature by leading the alliance launch process. This includes resourcing teams and leading kick-off meetings and ensuring a successful start to the collaboration
  • Be a key driver of the goals of the collaboration and manage the long-term relationships between Apellis and their partners by acting as the key-interface with respect to the management of the legal and contractual framework established for the alliances
  • Represent the Strategic Alliance Management team within relevant global franchises and work directly with stakeholder functions e.g. Legal, R&D, Commercial,Finance etc., to ensure harmonious collaboration and alignment with corporate BD strategy
  • Support the strategy, development, and execution of durable, effective alliances by partnering with colleagues in business development to help structure the right relationships before they begin and to ensure contract language represents feasible deliverables for Apellis and for our partners.
  • Liaise with business development in the event certain parts of the partnership contract require adaptation and renegotiation.
  • Serve as an Apellis ambassador by participating in industry and professional conferences and forums to further build company’s reputation in the marketplace
  • Lead process and decision-making around the conclusion or termination of alliances when they reach the end of their term or any other termination event.   

Education / Certifications:

  • Bachelor’s degree in Business or Science required
  • MBA is preferred
  • A Certified Strategic Alliance Professional will be a plus
Experience:

  • Minimum of 7 years industry experience in alliance management, operational management or strategic marketing, with responsibilities for pre-clinical and clinical and/or commercial stage collaborations.
  • Prior experience in both small Biotech and large Pharma environments is ideal.
  • Track record of having managed successful alliances, as well as a desire and ability to perform both at a strategic leadership level as well as in a hands-on capacity.
  • Previous experience in business development is desirable.
  • Prior experience in both small Biotech and large Pharma environments is ideal.
  • Understanding of the drug development process and working knowledge of the essential activities for all key functional areas.
  • Excellent interpersonal, oral, and written communication skills, including specifically, the skills needed to manage difficult conversations and interactions as they arise.
  • Strong communicator with the ability to work with scientific and commercial team members at all levels.
Skills, Knowledge & Abilities:
  • Excellent relationship skills to enable networking and ability to build strong relationships and alliances both inside and outside of the organization.
  • Strong leadership skills coupled with the ability to lead cross-functional teams.
  • Solid negotiation skills and will have a track record of successfully establishing alliances as part of the negotiation team

Benefits and Perks:

Apellis offers a great benefit package which includes: health insurance with full premium coverage, 401K with company match, paid time off (PTO), long- term disability insurance, life insurance and more!  Visit http://apellis.com/careerbenefits.html to learn more.

Company Background:

We are a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. We believe that this approach can result in broad inhibition of the principal pathways of the complement system and has the potential to effectively control a broad array of complement-dependent autoimmune and inflammatory diseases.

Visit http://apellis.com/about.html to learn more

EEO Statement: Apellis is an equal opportunity employer and complies with all applicable federal, state and local fair employment practices laws. Apellis strictly prohibits and does not tolerate discrimination against employees, applicants or any other covered persons because of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, marital status, AIDS/HIV status, smoker/nonsmoker, and occupational pneumocononiosis or any other characteristic protected under applicable federal, state or local law.